George E. Georges

Trials

Studies that name George E. Georges as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:55 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT04047628 · Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

  National Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis · study chair
• Ph2
  NCT00288626 · High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study

  National Institute of Allergy and Infectious Diseases (NIAID) · completed · Relapsing-Remitting Multiple Sclerosis · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 07:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Improving Engraftment of Hematopoietic Stem Cell Gene Therapy
  R01HL125183 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · fiscal years 2015 to 2017 · $814,260 awarded in 2017
  Same name and institution; not confirmed by an ID
• Improving Engraftment of Hematopoietic Stem Cell Gene Therapy
  R56HL125183 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · fiscal years 2014 · $837,496 awarded in 2014
  Same name and institution; not confirmed by an ID
• Radiation Dose-Dependent Interventions
  U19AI067770 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · fiscal years 2005 to 2010 · $11,616 awarded in 2010
  Same name and institution; not confirmed by an ID
• Immunosupression-Resistant Gene Modified Donor T Cells
  R01CA109381 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · fiscal years 2005 to 2009 · $323,970 awarded in 2009
  Same name and institution; not confirmed by an ID
• Improving Platelet Recovery After Radiation
  RC1AI080315 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · fiscal years 2008 · $666,667 awarded in 2008
  Same name and institution; not confirmed by an ID
• Mixed Chimerism as a Model for Adoptive Immunotherapy
  P01CA078902 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · fiscal years 2004 to 2008 · $313,917 awarded in 2008
  Same name and institution; not confirmed by an ID
• Improving Gastrointestinal Recovery after Radiation
  RC1AI078517 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · fiscal years 2007 · $1,000,000 awarded in 2007
  Same name and institution; not confirmed by an ID
• Cytokines for Immune Protection from Acute Irradiation
  R01AI066498 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · fiscal years 2005 · $1,500,000 awarded in 2005
  Same name and institution; not confirmed by an ID
• Gene Modified Donor T Cell Infusion into Mixed Chimeras
  R03DK062015 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · fiscal years 2002 to 2003 · $86,500 awarded in 2003
  Same name and institution; not confirmed by an ID
• GENE MODIFIED T-CELLS FOR ENGRAFTMENT AND GVHD CONTROL
  K08DK002753 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · fiscal years 1999 to 2003 · $126,630 awarded in 2003
  Same name and institution; not confirmed by an ID
• GENE MODIFIED T CELLS IN A MODEL TO CONTROL GVHD
  F32DK009718 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · fiscal years 1997 to 1998 · $37,012 awarded in 1998
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Immune Tolerance Network
  UM1AI109565 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Mark S Anderson, Jane Hoyt Buckner · fiscal years 2014 to 2026
  Named on NCT04047628